Aptamers Binding to c-Met Inhibiting Tumor Cell Migration.
The human receptor tyrosine kinase c-Met plays an important role in the control of critical cellular processes. Since c-Met is frequently over expressed or deregulated in human malignancies, blocking its activation is of special interest for therapy. In normal conditions, the c-Met receptor is activ...
Main Authors: | Birgit Piater, Achim Doerner, Ralf Guenther, Harald Kolmar, Bjoern Hock |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0142412&type=printable |
Similar Items
-
Selection of antibody-binding covalent aptamers
by: Noah Soxpollard, et al.
Published: (2024-08-01) -
Non-agonistic bivalent antibodies that promote c-MET degradation and inhibit tumor growth and others specific for tumor related c-MET.
by: Sameer A Greenall, et al.
Published: (2012-01-01) -
Development of bispecific anti-c-Met/PD-1 diabodies for the treatment of solid tumors and the effect of c-Met binding affinity on efficacy
by: Qingyun Yuan, et al.
Published: (2021-01-01) -
Binding Interactions of Peptide Aptamers
by: Roger R. C. New, et al.
Published: (2020-12-01) -
Novel Photochrome Aptamer Switch Assay (PHASA) for Adaptive Binding to Aptamers
by: Papper, Vladislav, et al.
Published: (2017)